Cagent Vascular: Funding, Investors & Team (Oct 2026)
Cagent Vascular creates a technology with serrations that enhances the treatment of cardiovascular conditions. Their angioplasty balloon, which utilizes this technology, is used to address blockages in the leg arteries caused by peripheral artery disease and chronic limb-threatening ischemia.
Cagent Vascular has raised $86.0M across 3 funding rounds on record, the most recent a Series D of $41.0M announced in May 2026.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Cagent Vascular Company Profile and Key Stats
Latest funding round on record: May 2026.
Cagent Vascular Funding Rounds
Cagent Vascular raised $30.0M in a Series C announced in Feb 2024.
1 years later, an undisclosed round of $15.0M was announced in Feb 2025.
1.3 years later, a Series D of $41.0M was announced in May 2026.
Cagent Vascular Founders and Leadership Team
Contact details for the Cagent Vascular team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Cagent Vascular Funding Compared to Other Health Care Startups
Cagent Vascular's latest round of $41.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cagent Vascular in Health Care and Wayne
Companies Similar to Cagent Vascular
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Cagent Vascular Funding FAQs
What does Cagent Vascular do?
Cagent Vascular creates a technology with serrations that enhances the treatment of cardiovascular conditions. Their angioplasty balloon, which utilizes this technology, is used to address blockages in the leg arteries caused by peripheral artery disease and chronic limb-threatening ischemia.
How much funding has Cagent Vascular raised?
Cagent Vascular has raised $86.0M across 3 rounds on record. The most recent is a Series D of $41.0M announced in May 2026.
When did Cagent Vascular last raise funding?
Cagent Vascular's most recent funding round on record is a Series D of $41.0M, announced in May 2026.
Who founded Cagent Vascular?
FundedIQ lists Brian Walsh (Founder), Carol A Burns (Founder) at Cagent Vascular.
Where is Cagent Vascular headquartered?
Cagent Vascular is based in Wayne, Pennsylvania, United States.
How many employees does Cagent Vascular have?
Cagent Vascular is in the 11-50 employee band.
How does Cagent Vascular's funding compare to other Health Care startups?
Cagent Vascular's latest round of $41.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Cagent Vascular Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cagent Vascular is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.